Announcements Trials

Browse Landscape

Phase

Status

Terminated 4 Completed 2 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 83 Fulvestrant 65 Trastuzumab 62 Letrozole 61 pembrolizumab 53 Carboplatin 51 Cyclophosphamide 48 pertuzumab 46 palbociclib 44 Anastrozole 41 Capecitabine 33 Tamoxifen 30 Magnetic Resonance Spectroscopy 29 exemestane 28 Radiotherapy 28 Doxorubicin 28 ribociclib 26 olaparib 26 Docetaxel 26 Specimen Handling 25 abemaciclib 24 130-nm albumin-bound paclitaxel 20 trastuzumab deruxtecan 19 Taxes 19 Gemcitabine 19 durvalumab 18 Surveys and Questionnaires 18 Epirubicin 18 eribulin 17 Alpelisib 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Dehydroepiandrosterone × Breast × Clear all

NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡